434 related articles for article (PubMed ID: 26321114)
1. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.
Ziff OJ; Lane DA; Samra M; Griffith M; Kirchhof P; Lip GY; Steeds RP; Townend J; Kotecha D
BMJ; 2015 Aug; 351():h4451. PubMed ID: 26321114
[TBL] [Abstract][Full Text] [Related]
2. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
[TBL] [Abstract][Full Text] [Related]
3. Interaction between digoxin and dronedarone in the PALLAS trial.
Hohnloser SH; Halperin JL; Camm AJ; Gao P; Radzik D; Connolly SJ;
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1019-25. PubMed ID: 25378467
[TBL] [Abstract][Full Text] [Related]
4. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
5. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
[TBL] [Abstract][Full Text] [Related]
6. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
Singh S; Moore H; Karasik PE; Lam PH; Wopperer S; Arundel C; Tummala L; Anker MS; Faselis C; Deedwania P; Morgan CJ; Zeng Q; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Dec; 133(12):1460-1470. PubMed ID: 32603789
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation.
Ouyang AJ; Lv YN; Zhong HL; Wen JH; Wei XH; Peng HW; Zhou J; Liu LL
Am J Cardiol; 2015 Apr; 115(7):901-6. PubMed ID: 25660972
[TBL] [Abstract][Full Text] [Related]
8. Non-compliance with digoxin in patients with heart failure and/or atrial fibrillation: a systematic review and meta-analysis of observational studies.
Kongkaew C; Sakunrag I; Jianmongkol P
Arch Cardiovasc Dis; 2012 Oct; 105(10):507-16. PubMed ID: 23062482
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation.
Qureshi W; O'Neal WT; Soliman EZ; Al-Mallah MH
Cardiol J; 2016; 23(3):333-43. PubMed ID: 27064796
[TBL] [Abstract][Full Text] [Related]
10. The effect of digoxin on mortality and morbidity in patients with heart failure.
Digitalis Investigation Group
N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
[TBL] [Abstract][Full Text] [Related]
11. Digoxin: The good and the bad.
Ziff OJ; Kotecha D
Trends Cardiovasc Med; 2016 Oct; 26(7):585-95. PubMed ID: 27156593
[TBL] [Abstract][Full Text] [Related]
12. Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.
Adams KF; Butler J; Patterson JH; Gattis Stough W; Bauman JL; van Veldhuisen DJ; Schwartz TA; Sabbah H; Mackowiak JI; Ventura HO; Ghali JK
Eur J Heart Fail; 2016 Aug; 18(8):1072-81. PubMed ID: 27492641
[TBL] [Abstract][Full Text] [Related]
13. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
[TBL] [Abstract][Full Text] [Related]
14. Digoxin and prognosis of heart failure in older patients with preserved ejection fraction: Importance of heart rate. Results from an observational and multicenter study.
Llàcer P; Núñez J; Bayés-Genís A; Conde Martel A; Cabanes Hernández Y; Díez Manglano J; Álvarez Rocha P; Soler Rangel L; Gómez Del Olmo V; Manzano L; Montero Pérez-Barquero M
Eur J Intern Med; 2019 Feb; 60():18-23. PubMed ID: 30360944
[TBL] [Abstract][Full Text] [Related]
15. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
[TBL] [Abstract][Full Text] [Related]
16. Digoxin-associated mortality: a systematic review and meta-analysis of the literature.
Vamos M; Erath JW; Hohnloser SH
Eur Heart J; 2015 Jul; 36(28):1831-8. PubMed ID: 25939649
[TBL] [Abstract][Full Text] [Related]
17. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
[TBL] [Abstract][Full Text] [Related]
18. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
Ahmed A; Rich MW; Fleg JL; Zile MR; Young JB; Kitzman DW; Love TE; Aronow WS; Adams KF; Gheorghiade M
Circulation; 2006 Aug; 114(5):397-403. PubMed ID: 16864724
[TBL] [Abstract][Full Text] [Related]
19. Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.
Sethi NJ; Safi S; Feinberg J; Nielsen EE; Gluud C; Jakobsen JC
Syst Rev; 2017 Apr; 6(1):71. PubMed ID: 28381269
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
